Article info
PDFChronic obstructive pulmonary disease
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial
- Professor Qutayba Hamid, Meakins Christie Laboratories, McGill University, 3626 St Urbain Street, Montreal, Quebec, Canada H2X 2P2; qutayba.hamid{at}mcgill.ca
Citation
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial
Publication history
- Received August 31, 2006
- Accepted April 5, 2007
- First published June 8, 2007.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2007 BMJ Publishing Group and British Thoracic Society